A population-based study of incidence trends of head and neck epithelial cancers in northeastern Spain, 1994-2018.

IF 2.8 3区医学 Q2 ONCOLOGY

Clinical & Translational Oncology Pub Date : 2025-02-19 DOI:10.1007/s12094-025-03855-8

Jordi Rubió-Casadevall, Jan Trallero, Carla Calvo, Montse Puigdemont, Marià Carulla, Arantza Sanvisens, Alberto Ameijide, Anna Vidal, Clàudia Pla, Jordi Marruecos, Rafael Marcos-Gragera, Jaume Galceran

{"title":"A population-based study of incidence trends of head and neck epithelial cancers in northeastern Spain, 1994-2018.","authors":"Jordi Rubió-Casadevall, Jan Trallero, Carla Calvo, Montse Puigdemont, Marià Carulla, Arantza Sanvisens, Alberto Ameijide, Anna Vidal, Clàudia Pla, Jordi Marruecos, Rafael Marcos-Gragera, Jaume Galceran","doi":"10.1007/s12094-025-03855-8","DOIUrl":null,"url":null,"abstract":"Background: Head and neck cancer (HNC) is the seventh most common cancer worldwide. Incidence rates of these tumors vary between countries and change over time depending on the prevalence of risk factors such as tobacco and alcohol consumption, betel nut chewing habits or human papillomavirus infection. This makes it necessary to periodically study HNC incidence trends in each geographic area.Methods: To determine trends in the incidence of HNC, all cancer cases diagnosed in Girona and Tarragona (northeastern Spain) between 1994 and 2018, except mesenchymal and hematological neoplasms, were included. Crude and standardized incidence rates and the annual percentage change (APC) were calculated.Results: We identify 7,966 cases of HNC, 83.7% in men. A significant decrease in incidence, with an APC of - 1.83, was observed in all HNC as a whole and in cancers of the lip (APC = - 5.34), salivary glands (APC = - 2.22), nasopharynx (APC = - 2.01), hypopharynx (APC = - 3.15), and larynx (APC = - 1.97). In men, a significant decline in incidence was observed in overall HNC and in cancers of the lip, oral cavity, salivary glands, nasopharynx, hypopharynx, and larynx. In women, a significant increase was identified in overall HNC and in cancers of oral cavity, oropharynx, hypopharynx, and larynx.Conclusion: A decline in the overall incidence of HNC has been observed in this area of southern Europe, mainly based on a decrease in men of cancers of the lip, oral cavity, salivary glands, nasopharynx, hypopharynx, and larynx.","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-025-03855-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Head and neck cancer (HNC) is the seventh most common cancer worldwide. Incidence rates of these tumors vary between countries and change over time depending on the prevalence of risk factors such as tobacco and alcohol consumption, betel nut chewing habits or human papillomavirus infection. This makes it necessary to periodically study HNC incidence trends in each geographic area.

Methods: To determine trends in the incidence of HNC, all cancer cases diagnosed in Girona and Tarragona (northeastern Spain) between 1994 and 2018, except mesenchymal and hematological neoplasms, were included. Crude and standardized incidence rates and the annual percentage change (APC) were calculated.

Results: We identify 7,966 cases of HNC, 83.7% in men. A significant decrease in incidence, with an APC of - 1.83, was observed in all HNC as a whole and in cancers of the lip (APC = - 5.34), salivary glands (APC = - 2.22), nasopharynx (APC = - 2.01), hypopharynx (APC = - 3.15), and larynx (APC = - 1.97). In men, a significant decline in incidence was observed in overall HNC and in cancers of the lip, oral cavity, salivary glands, nasopharynx, hypopharynx, and larynx. In women, a significant increase was identified in overall HNC and in cancers of oral cavity, oropharynx, hypopharynx, and larynx.

Conclusion: A decline in the overall incidence of HNC has been observed in this area of southern Europe, mainly based on a decrease in men of cancers of the lip, oral cavity, salivary glands, nasopharynx, hypopharynx, and larynx.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical & Translational Oncology 医学-肿瘤学

CiteScore

6.20

自引率

2.90%

发文量

240

审稿时长

1 months

期刊介绍： Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.